Related Experiment Video
Updated: Dec 8, 2025
05:25
Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
Published on: October 24, 2025
182
Robotic Neck Dissection
Neal Rajan Godse1, Toby Shen Zhu2, Umamaheswar Duvvuri3
1Department of Otolaryngology, University of Pittsburgh, 203 Lothrop Street, Suite 500, Pittsburgh, PA 15213, USA.
Otolaryngologic Clinics of North America
|September 18, 2020
Summary
Robot-assisted neck dissection is an emerging alternative to open surgery for head and neck squamous cell carcinoma. Further research is needed to confirm its long-term effectiveness and efficiency.
Area of Science:
- Oncology
- Surgical Innovation
- Head and Neck Cancer Management
Background:
- Head and neck squamous cell carcinoma (HNSCC) requires a multimodal treatment strategy.
- Neck dissection is a cornerstone surgical procedure for managing nodal metastasis in HNSCC.
- Open neck dissection remains the established gold standard surgical technique.
Purpose of the Study:
- To introduce robot-assisted neck dissection as a contemporary surgical alternative.
- To highlight the need for further investigation into robot-assisted surgical outcomes.
- To evaluate the potential benefits of robot-assisted surgery in terms of cost and operative time.
Main Methods:
- Review of current surgical management strategies for HNSCC.
- Introduction of robot-assisted neck dissection as an evolving technique.
- Emphasis on the necessity for comparative outcome studies.
Main Results:
- Open neck dissection is the current gold standard for nodal disease in HNSCC.
- Robot-assisted neck dissection presents a novel alternative surgical approach.
- Long-term oncologic outcomes and efficiency metrics for robot-assisted surgery require further validation.
Conclusions:
- The management of HNSCC involves a multimodal approach with neck dissection being pivotal.
- Robot-assisted neck dissection is a developing option that warrants comprehensive evaluation.
- Future research should focus on establishing the oncologic efficacy and economic viability of robot-assisted procedures.
